IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 60 filers reported holding IMMUNE DESIGN CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $474,000 | +478.0% | 80,936 | +28.6% | 0.00% | – |
Q4 2018 | $82,000 | -62.4% | 62,943 | 0.0% | 0.00% | – |
Q3 2018 | $218,000 | -12.1% | 62,943 | +15.6% | 0.00% | – |
Q2 2018 | $248,000 | +37.8% | 54,443 | -0.2% | 0.00% | – |
Q1 2018 | $180,000 | -15.5% | 54,543 | 0.0% | 0.00% | – |
Q4 2017 | $213,000 | -39.8% | 54,543 | +59.7% | 0.00% | – |
Q3 2017 | $354,000 | +122.6% | 34,143 | +110.2% | 0.00% | – |
Q2 2017 | $159,000 | +43.2% | 16,243 | 0.0% | 0.00% | – |
Q1 2017 | $111,000 | +23.3% | 16,243 | 0.0% | 0.00% | – |
Q4 2016 | $90,000 | -27.4% | 16,243 | 0.0% | 0.00% | – |
Q3 2016 | $124,000 | -6.8% | 16,243 | 0.0% | 0.00% | – |
Q2 2016 | $133,000 | -37.3% | 16,243 | 0.0% | 0.00% | – |
Q1 2016 | $212,000 | -35.2% | 16,243 | 0.0% | 0.00% | – |
Q4 2015 | $327,000 | +64.3% | 16,243 | 0.0% | 0.00% | – |
Q3 2015 | $199,000 | -40.8% | 16,243 | 0.0% | 0.00% | – |
Q2 2015 | $336,000 | +32.8% | 16,243 | +98.1% | 0.00% | – |
Q4 2014 | $253,000 | – | 8,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Svennilson Peter | 6,642,942 | $8,636,000 | 7.61% |
Versant Venture Management, LLC | 2,208,210 | $2,870,673,000 | 1.42% |
BVF INC/IL | 5,185,383 | $6,741,000 | 0.88% |
EcoR1 Capital, LLC | 5,603,191 | $7,284,000 | 0.73% |
Abingworth LLP | 352,300 | $458,000 | 0.42% |
Bain Capital Public Equity Management, LLC | 892,061 | $1,160,000 | 0.11% |
ALGERT GLOBAL LLC | 92,591 | $120,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 41,068 | $53,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 136,468 | $177,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 27,122 | $35,000 | 0.01% |